Does RISANKIZUMAB-RZAA Cause Rash macular? 203 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 203 reports of Rash macular have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
203
Reports of Rash macular with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
0
Deaths
35
Hospitalizations
How Dangerous Is Rash macular From RISANKIZUMAB-RZAA?
Of the 203 reports, 35 (17.2%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Rash macular Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 203 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Rash macular?
ADAPALENE (3,987)
DUPILUMAB (3,771)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (3,092)
ADALIMUMAB (1,407)
LENALIDOMIDE (632)
ETANERCEPT (627)
SECUKINUMAB (552)
IBRUTINIB (375)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (371)
APIXABAN (279)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Rash macular Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA